IDEXX LABORATORIES INC /DE Available-for-sale Securities
IDEXX LABORATORIES INC /DE (IDXX) had Available-for-sale Securities of $284.25 million as of 2017-12-31, per its 10-Q filed 2018-08-01.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2018-08-01
- 2017-12-31: Available-for-sale Securities $284.25M.
- 2017-09-30: Available-for-sale Securities $285.08M.
- 2017-06-30: Available-for-sale Securities $256.92M.
- 2017-03-31: Available-for-sale Securities $239.93M.
| Period end | Available-for-sale Securities |
|---|---|
| 2017-12-31 | $284.25M 10-Q · filed 2018-08-01 |
| 2017-09-30 | $285.08M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $256.92M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $239.93M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $236.95M 10-K · filed 2018-02-16 |
| 2016-09-30 | $241.40M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $229.06M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $217.62M 10-Q · filed 2016-04-29 |
| 2015-12-31 | $213.59M 10-K · filed 2017-02-17 |
| 2015-09-30 | $208.40M 10-Q · filed 2015-10-28 |
| 2015-06-30 | $180.87M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $139.22M 10-Q · filed 2015-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |